From a Vision for Access to a Movement for Medication Justice
Med Aditus Foundation (MAF) is a 501(c)(3) nonprofit organization committed to advancing medication justice across sub-Saharan Africa.
The organization was founded in 2019 by Dhiren Thakker as Med Aditus International (MAI) with a vision of improving access to safe, affordable, quality-assured medicines.
As that vision evolved, MAI focused on the root causes of the lack of access to medicines and the infiltration of substandard and falsified medicines in sub-Saharan Africa: the insufficient local manufacturing capacity. MAI then launched two spin-off companies, Med Aditus Pharmaceuticals, Inc. (MAP) and its Kenyan affiliate, Med Aditus Pharmaceuticals Kenya, Ltd. (MAK) to promote the rapid growth of local pharmaceutical manufacturing capacity by deploying innovative technologies, while its nonprofit work increasingly focused on education, research, workforce development, and public engagement. In 2025, MAI’s nonprofit activities were formally rebranded as MAF, reflecting a broader mission to address the systemic factors that influence equitable access to medicines.
Timeline of Evolution
MAI Founded
Dheren Thakker, Ph.D., establishes Med Aditus International (MAI) to improve access to quality medicines & strengthen domestic pharmaceutical manufacturing capacity in Africa.
MAP & MAK Established
MAP and its Kenyan subsidiary, MAK, were launched by MAI to support its mission to produce quality, affordable pharmaceutics in sub-Saharan Africa, and promote the growth of local pharmaceutical manufacturing capacity.
Leadership
Robert Blouin , Pharm.D., appointed President & CEO of MAI. Organizational vision expands beyond medicines to people & communities.
Dheren Thakker, Ph.D.,appointed President & CEO of MAP and MAK, with a commitment to build MAK by recruiting local talent.
Kisumu Partnerships
MAI, MAP & MAK enter joint strategic partnerships with Kisumu County and Great Lakes University of Kisumu (GLUK).
Reboot
MAI's nonprofit efforts are rebranded as MAF and the following initiatives are developed: Med Aditus Presents, Sickle Cell Partnership for Advocacy, Research and Knowledge; Young African Women's Leadership Program; Anti-Misinformation Campaigns; and Regional Pharmaceutical Workforce Resilience Program.
Across sub-Saharan Africa, millions of people continue to face barriers to accessing essential medicines.
The Challenges
These challenges extend far beyond medicine availability and are shaped by fragmented supply chains, limited pharmaceutical manufacturing capacity, workforce shortages, weak health systems, and the continued circulation of substandard and falsified medicines. MAF defines these interconnected challenges as medication injustice.
The Meaning Behind Med Aditus
The name Med Aditus reflects the organization's founding philosophy. Derived from the Latin word “Aditus”, meaning access, entrance, or passageway, it represents the belief that access to quality medicines should never depend on geography, income, or circumstance.
Evolving Understanding of Medication Access
Since its founding in 2019, the organization's understanding of medication access has continued to evolve. Improving access to medicines requires increasing local pharmaceutical production but it also depends on developing skilled workforces, generating evidence through research, strengthening institutions, fostering public trust, and supporting locally led solutions. This broader understanding became the basis of what Med Aditus refers to as a medication justice ecosystem.
A Medication Justice Ecosystem
Medication injustice cannot be solved by a single organization or through a single intervention. It requires coordinated efforts. Within this ecosystem, each organization contributes to the mission through a distinct but complementary role.
The Role of MAF, MAP and MAK
MAF serves as the nonprofit organization, advancing education, workforce development, research, policy engagement, and public understanding of medication access challenges. Through strategic partnerships and community-based initiatives, MAF works to strengthen the people, knowledge, and institutions needed for sustainable access to quality medicines.
MAP and MAK operate independently from MAF, advancing innovation in pharmaceutical manufacturing, and promoting growth of local pharmaceutical manufacturing through their own initiatives.
Our Vision
We aim to support African countries in building the knowledge, workforce, institutions, and pharmaceutical capacity needed to sustainably improve access to quality medicines. We advance this vision by investing in the people, partnerships, and systems that make lasting access to safe, affordable, and quality-assured medicines possible.